: 23725400  [PubMed - indexed for MEDLINE]435. Anesthesiol Clin. 2013 Jun;31(2):321-53. doi: 10.1016/j.anclin.2012.12.003.Advances and future directions for mechanical circulatory support.Capdeville M(1), Smedira NG.Author information: (1)Department of Cardiothoracic Anesthesia, Cleveland Clinic, 9500 Euclid Avenue,J4-331, Cleveland, OH 44195, USA. capdevm@ccf.orgAlthough cardiac transplant remains the gold standard for the treatment ofend-stage heart failure, limited donor organ availability and growing numbers of eligible recipients have increased the demand for alternative therapies.Limitations of first-generation left ventricular assist devices for long-termsupport of patients with end-stage disease have led to the development of newersecond-generation and third-generation pumps, which are smaller, have fewermoving parts, and have shown improved durability, allowing for extended support. The HeartMate II (second generation) and HeartWare (third generation) are 2devices that have shown great promise as potential alternatives totransplantation in select patients.Copyright Â© 2013 Elsevier Inc. All rights reserved.